DEEPGEN powered liquid biopsy offers dozens of different research applications across 5 clinical areas and 15 cancer types.
The genes and mutations tested have been previously demonstrated to be involved in cancer. We identified this core spectrum of genes and mutations as the most likely candidates as biomarkers for the development and/or recurrence of cancer.
• Our Serenity software and portal system allow for efficient workflow and reduced timelines for test results
• The entire process is completely paperless and automated
• All aspects of the process go through the portal from intake, to check-in to delivery of results
• The portal can be customized as needed based on production specific process and needs
• SARS-CoV-2 RT-PCR diagnostic test for the detection of live virus (vs. rapid antigen)
• FDA EUA-approved, CDC and SAG-compliant
• 100% specificity and sensitivity historically confirmed in real-world operations across ~100,000 test
• Mid-nasal, nasopharyngeal and oral swab test formats available
• Conveniently located CLIA-certified laboratory headquarters in Santa Monica, CA
• Fully staffed operating under the director of our laboratory director and CLS
• Able to process samples at scale.
In accordance with CDC guidelines, we offer FDA EUA-certified nasopharyngeal PCR testing. In addition, we provide licensed and trained sample collection specialists to ensure tests are administered in accordance with CDC recommended methods. With accurate collection this test has been shown to deliver 99.9% sensitivity and specificity.
